Literature DB >> 34265022

SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.

Magen Ellen Francis1,2, Una Goncin3, Andrea Kroeker1, Cynthia Swan1, Robyn Ralph1,4, Yao Lu1, Athema Louise Etzioni5, Darryl Falzarano1,4, Volker Gerdts1, Steven Machtaler3, Jason Kindrachuk1,6, Alyson Ann Kelvin1,7,8,9.   

Abstract

COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a disease affecting several organ systems. A model that captures all clinical symptoms of COVID-19 as well as long-haulers disease is needed. We investigated the host responses associated with infection in several major organ systems including the respiratory tract, the heart, and the kidneys after SARS-CoV-2 infection in Syrian hamsters. We found significant increases in inflammatory cytokines (IL-6, IL-1beta, and TNF) and type II interferons whereas type I interferons were inhibited. Examination of extrapulmonary tissue indicated inflammation in the kidney, liver, and heart which also lacked type I interferon upregulation. Histologically, the heart had evidence of myocarditis and microthrombi while the kidney had tubular inflammation. These results give insight into the multiorgan disease experienced by people with COVID-19 and possibly the prolonged disease in people with post-acute sequelae of SARS-CoV-2 (PASC).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34265022     DOI: 10.1371/journal.ppat.1009705

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  22 in total

Review 1.  Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes.

Authors:  Shambhunath Choudhary; Isis Kanevsky; Lindsay Tomlinson
Journal:  Vet Pathol       Date:  2022-04-22       Impact factor: 3.157

Review 2.  Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection.

Authors:  Oleksandr Dmytrenko; Kory J Lavine
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

3.  SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.

Authors:  Federico Armando; Georg Beythien; Franziska K Kaiser; Malgorzata Ciurkiewicz; Albert D M E Osterhaus; Wolfgang Baumgärtner; Lisa Allnoch; Laura Heydemann; Malgorzata Rosiak; Svenja Becker; Mariana Gonzalez-Hernandez; Mart M Lamers; Bart L Haagmans; Kate Guilfoyle; Geert van Amerongen
Journal:  Nat Commun       Date:  2022-06-20       Impact factor: 17.694

4.  Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.

Authors:  Rakesh Kulkarni; Wen-Ching Chen; Ying Lee; Chi-Fei Kao; Shiu-Lok Hu; Hsiu-Hua Ma; Jia-Tsrong Jan; Chun-Che Liao; Jian-Jong Liang; Hui-Ying Ko; Cheng-Pu Sun; Yin-Shoiou Lin; Yu-Chiuan Wang; Sung-Chan Wei; Yi-Ling Lin; Che Ma; Yu-Chan Chao; Yu-Chi Chou; Wen Chang
Journal:  PLoS One       Date:  2021-09-09       Impact factor: 3.752

5.  The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.

Authors:  Ali Zaid; Adam Taylor; Suresh Mahalingam; Xiang Liu; Helen Mostafavi; Wern Hann Ng; Joseph R Freitas; Nicholas J C King
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 6.  Type I interferons and SARS-CoV-2: from cells to organisms.

Authors:  Paul Bastard; Qian Zhang; Shen-Ying Zhang; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2022-01-25       Impact factor: 7.486

7.  Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.

Authors:  Haoran Peng; Cuiling Ding; Liangliang Jiang; Wanda Tang; Yan Liu; Lanjuan Zhao; Zhigang Yi; Hao Ren; Chong Li; Yanhua He; Xu Zheng; Hailin Tang; Zhihui Chen; Zhongtian Qi; Ping Zhao
Journal:  Sci China Life Sci       Date:  2021-12-24       Impact factor: 10.372

8.  Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection.

Authors:  Zaigham Abbas Rizvi; Rajdeep Dalal; Srikanth Sadhu; Akshay Binayke; Jyotsna Dandotiya; Yashwant Kumar; Tripti Shrivastava; Sonu Kumar Gupta; Suruchi Aggarwal; Manas Ranjan Tripathy; Deepak Kumar Rathore; Amit Kumar Yadav; Guruprasad R Medigeshi; Amit Kumar Pandey; Sweety Samal; Shailendra Asthana; Amit Awasthi
Journal:  Elife       Date:  2022-01-11       Impact factor: 8.140

9.  Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge.

Authors:  Ting Y Wong; Katherine S Lee; Brynnan P Russ; Alexander M Horspool; Jason Kang; Michael T Winters; M Allison Wolf; Nathaniel A Rader; Olivia A Miller; Morgane Shiflett; Jerilyn Izac; David Varisco; Emel Sen-Kilic; Casey Cunningham; Melissa Cooper; Holly A Cyphert; Mariette Barbier; Ivan Martinez; Justin R Bevere; Robert K Ernst; F Heath Damron
Journal:  NPJ Vaccines       Date:  2022-03-14       Impact factor: 7.344

10.  Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.

Authors:  Sreelekshmy Mohandas; Pragya D Yadav; Anita Shete; Dimpal Nyayanit; Rajlaxmi Jain; Gajanan Sapkal; Chandrashekhar Mote
Journal:  Viruses       Date:  2022-03-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.